Home › Triglycerides › New York
Triglycerides clinical trials in New York
5 studies for Triglycerides are looking for participants at sites in New York.
Cities in New York
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
- Weill Cornell Medical College, New York
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07269210Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
- Research Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06880770A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- University of Rochester, Rochester
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07491172Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- Research Site 72, Long Island City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06822790Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Clinical Study Center, New York
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jul 17, 2026 · NCT06451770From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.